Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression

BACKGROUND: Treatment for non-small cell lung cancer (NSCLC) has greatly improved in recent years. However, noninvasive early screening for carcinogenesis and progression unclear. The aim of this study was to explore the predictive value of peripheral blood immune cells in untreated NSCLC patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yingyi, Zhou, Na, Zhu, Rui, Li, Xiaoyuan, Sun, Zhao, Gao, Yang, Liu, Wei, Meng, Changting, Ge, Yuping, Bai, Chunmei, Li, Taisheng, Liu, Hongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420051/
https://www.ncbi.nlm.nih.gov/pubmed/34488711
http://dx.doi.org/10.1186/s12890-021-01636-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420051/
https://www.ncbi.nlm.nih.gov/pubmed/34488711
http://dx.doi.org/10.1186/s12890-021-01636-x

Ejemplares similares